189 related articles for article (PubMed ID: 12507400)
41. CD4-veCD8-ve CD30+ve T cells are detectable in human lung transplant patients and their proportion of the lymphocyte population after in vitro stimulation with donor spleen cells correlates with preservation of lung physiology.
Polster K; Walker A; Fildes J; Entwistle G; Yonan N; Hutchinson IV; Leonard CT
Transplant Proc; 2005 Jun; 37(5):2257-60. PubMed ID: 15964393
[TBL] [Abstract][Full Text] [Related]
42. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
[TBL] [Abstract][Full Text] [Related]
43. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
44. T cells in sputum of asthmatic patients are activated independently of disease severity or control.
Lourenço O; Mafalda Fonseca A; Taborda-Barata L
Allergol Immunopathol (Madr); 2009; 37(6):285-92. PubMed ID: 19850398
[TBL] [Abstract][Full Text] [Related]
45. Kinetics of T cell-activation molecules in response to Mycobacterium tuberculosis antigens.
Antas PR; Oliveira EB; Milagres AS; Franken KC; Ottenhoff TH; Klatser P; Sarno EN; Sampaio EP
Mem Inst Oswaldo Cruz; 2002 Dec; 97(8):1097-9. PubMed ID: 12563472
[TBL] [Abstract][Full Text] [Related]
46. Role of CD4+ and CD8+ T cells in early and late acute rejection of small bowel allograft.
Guo WH; Tian L; Chan KL; Dallman M; Tam PK
J Pediatr Surg; 2001 Feb; 36(2):352-6. PubMed ID: 11172433
[TBL] [Abstract][Full Text] [Related]
47. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants.
Fischbein MP; Ardehali A; Yun J; Schoenberger S; Laks H; Irie Y; Dempsey P; Cheng G; Fishbein MC; Bonavida B
J Immunol; 2000 Dec; 165(12):7316-22. PubMed ID: 11120867
[TBL] [Abstract][Full Text] [Related]
48. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
49. Activation and maturation of alloreactive CD4-independent, CD8 cytolytic T cells.
Lunsford KE; Horne PH; Koester MA; Eiring AM; Walker JP; Dziema HL; Bumgardner GL
Am J Transplant; 2006 Oct; 6(10):2268-81. PubMed ID: 16889609
[TBL] [Abstract][Full Text] [Related]
50. Induction of CD69 antigen on normal CD4+ and CD8+ lymphocyte subsets and its relationship with the phenotype of responding T-cells.
Rutella S; Rumi C; Lucia MB; Barberi T; Puggioni PL; Lai M; Romano A; Cauda R; Leone G
Cytometry; 1999 Jun; 38(3):95-101. PubMed ID: 10397327
[TBL] [Abstract][Full Text] [Related]
51. Studies on the participation of different T cell subsets in rat liver allograft rejection. Comparison of liver with heart graft.
Sumimoto R; Kimura H; Yamaguchi A; Kamada N
Transpl Int; 1992; 5 Suppl 1():S636-8. PubMed ID: 14621896
[TBL] [Abstract][Full Text] [Related]
52. Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus.
Crispin JC; Martínez A; de Pablo P; Velasquillo C; Alcocer-Varela J
Scand J Immunol; 1998 Aug; 48(2):196-200. PubMed ID: 9716112
[TBL] [Abstract][Full Text] [Related]
53. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
54. CD4
Piersiala K; Farrajota Neves da Silva P; Hjalmarsson E; Kolev A; Kågedal Å; Starkhammar M; Elliot A; Marklund L; Margolin G; Munck-Wikland E; Kumlien Georén S; Cardell LO
Cancer Sci; 2021 Mar; 112(3):1048-1059. PubMed ID: 33462898
[TBL] [Abstract][Full Text] [Related]
55. In vivo differentiation of alloreactive CD8+ T cells after murine cardiac allograft transplantation.
Gilot BJ; Hara M; Jones ND; van Maurik A; Hadjianastassiou V; Morris PJ; Wood KJ
Transplant Proc; 1999; 31(1-2):130. PubMed ID: 10083042
[No Abstract] [Full Text] [Related]
56. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
57. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
58. 24-hour immunologic assessment of CD4+ and CD8+ lymphocytes in renal transplant recipients receiving chronic methylprednisolone.
Tornatore KM; Reed K; Venuto R
Clin Nephrol; 1995 Nov; 44(5):290-8. PubMed ID: 8605708
[TBL] [Abstract][Full Text] [Related]
59. Cytokines and cell surface markers in prediction of cardiac allograft rejection.
Chang DM; Ding YA; Kuo SY; Chang ML; Wei J
Immunol Invest; 1996; 25(1-2):13-21. PubMed ID: 8675230
[TBL] [Abstract][Full Text] [Related]
60. Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy.
Athanassopoulos P; Vaessen LM; Balk AH; Takkenberg JJ; Maat AP; Weimar W; Bogers AJ
Eur J Cardiothorac Surg; 2005 May; 27(5):783-9. PubMed ID: 15848314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
